Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial

✍ Scribed by de Nully Brown, P; Hoffmann, T; Hansen, O P; Boesen, A M; Grønbæk, K; Hippe, E; Jensen, M K; Thorling, K; Storm, H H; Pedersen-Bjergaard, J

• Book ID: 110053379
• Publisher: Nature Publishing Group
• Year: 1997
• Tongue: English
• Weight: 88 KB
• Volume: 11
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/sj.leu.2400514